BioSpace News Archive

Datatrak International, Inc. (OTC Markets: DTRK), a worldwide Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the life sciences industry, today announced they will be demonstrating their newest product, Datatrak Direct Enterprise Cloud, at the Annual DIA meeting in San Diego.

Tekni-Plex has completed the acquisition of three manufacturing facilities from Amcor’s Flexible Packaging business unit.

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) has approved the merger of Jefferson College of Health Sciences into Radford University, thereby formally establishing Radford University Carilion (RUC), an educational site located in Roanoke, Virginia focused on the delivery of health sciences programming.

$920K Awards Honor Princeton Astrophysicist James Gunn, University of Rochester Chemist Ching Tang, and Théâtre du Soleil Founder Ariane Mnouchkine

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Puneet Sarin to worldwide president, BD Biosciences, effective today.

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce the details of an oral presentation on the results of the Company’s NAV3-21 clinical study at the Society of Nuclear Medicine and Molecular Imaging (“SNMMI”) Annual Meeting in Anaheim, CA.

Shimadzu Scientific Instruments (SSI) announces the release of the iSpect DIA-10 dynamic particle image analysis system, which performs particle imaging, size analysis and foreign object detection, in addition to obtaining size distributions and number concentration, in as little as two minutes.

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Victoza® (liraglutide) injection to lower blood sugar along with diet and exercise in children and adolescents aged 10-17 years with type 2 diabetes.

Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a developer, manufacturer and service provider of advanced cell therapies, announces that the United States Food & Drug Administration (FDA) has granted Orphan Drug designation for its Autologous Insulin Producing (AIP) cells as a cell replacement therapy for the treatment of severe hypoglycemia-prone diabetes resulting from total pancreatectomy (TP) due to chronic pancreatitis (CP)

Accolade and EY announced that Rajeev Singh, CEO of Accolade, a personalized advocacy solution for employers and their members, received the Entrepreneur Of The Year® 2019 Award in the Innovator category, Pacific Northwest region.